课题基金 / 基金详情

SBIR Phase I: Unique Biomaterial for Long-Term Culturing of Hematopoietic Stem Cells in Vitro

SBIR Phase I: Unique Biomaterial for Long-Term Culturing of Hematopoietic Stem Cells in Vitro
SBIR 第一期:用于体外长期培养造血干细胞的独特生物材料
批准号:
9661006
负责人:
Mark Pykett
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 1997-06-30

项目摘要

项目成果

Mark Pykett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
*** 9661006 Pykett In this Small Business Innovation Research Phase I project, Cytomatrix proposes to examine the ability of a unique three-dimensional biomaterial, Cellfoam TM, to support the long-term culturing of hematopoietic stem cells (HSCs) in vitro. The ability to culture stem cells in vitro over prolonged periods is paramount to many areas of basic research and clinical medicine, yet current culture systems have proven ineffective in sustaining HSCs for extended periods, perhaps because traditional monolayer cultures lack the natural three-dimensional topography found in vivo. Thus, there is urgent need for the development of novel culture systems capable of sustaining HSCs. Preliminary results have shown that Cellfoam is capable of enhancing short- term stem cell survival in vitro compared to conventional systems without compromising HSC survival or pluripotency. This project will evaluate the ability of Cellfoam to sustain HSCs in vitro over extended periods and will assess the impact of long-term culture on stem cell biology. Specifically, the survival, phenotype, and multipotency of HSCs cultured for six weeks in Cellfoam will be measured and compared to conventional systems. Based on previous successes with short-term Cellfoam cultures, it is anticipated that Cellfoam will improve the long-term maintenance of stem cell viability. The Phase I research results will be instrumental in developing advanced culture systems for the maintenance and manipulation of HSCs. Cellfoam TM systems will enable, for the first time, the maintenance, analysis, and manipulation of hematopoietic stem cells over extended periods. Commercial applications of Cellfoam devices will take advantage of existing markets in basic science and clinical medicine in which such systems are required but unavailable. Applications foster fundamental advances in research and clinical fields, including gene therapy, bone marrow transplantation, and transfusion medicine, and thus have the potential for sign ificant impact on basic as well as clinical disciplines. ***
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR Phase I: Neural Plasticity of Bone Marrow Derived Progenitor Cells
  • 批准号:
    0320047
  • 项目类别:
    Standard Grant
  • 资助金额:
    $9.87万
  • 财政年份:
    2003
  • 负责人:
    Mark Pykett
  • 依托单位:
SBIR Phase II: Selection and Storage of Hematopoietic Stem Cells in a Novel Bioreactor
  • 批准号:
    9901698
  • 项目类别:
    Standard Grant
  • 资助金额:
    $39.85万
  • 财政年份:
    1999
  • 负责人:
    Mark Pykett
  • 依托单位:
SBIR Phase I: Selection and Storage of Cord Blood Stem Cells in a Novel Bioreactor
  • 批准号:
    9760236
  • 项目类别:
    Standard Grant
  • 资助金额:
    $8.82万
  • 财政年份:
    1998
  • 负责人:
    Mark Pykett
  • 依托单位:
SBIR Phase II: Unique Biomaterial for Extended Culture, Expansion and Transduction of Hematopoietic Stem Cells in Vitro
  • 批准号:
    9800926
  • 项目类别:
    Standard Grant
  • 资助金额:
    $39.85万
  • 财政年份:
    1998
  • 负责人:
    Mark Pykett
  • 依托单位:
国内基金
海外基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YUICHIRO NAKAI
  • 依托单位:
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    3350万元
  • 批准年份:
    2019
  • 负责人:
    刘衍文
  • 依托单位:
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2018
  • 负责人:
    张里
  • 依托单位:
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究